ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Abstracts tagged "complement deficiency"

  • Abstract Number: 1766 • ACR/ARHP Annual Meeting 2017

    Increased Renal Damage in Hypocomplementemic Patients with ANCA- Associated Vasculitis

    Lucila GarcĂ­a1, Claudia Elizabeth Pena2, Mariana Pera3, Mercedes Garcia2, Valeria Arturi3, Viviana Nagua1, Rodrigo Aguila Maldonado2, Ana Carolina Costi2, Adriana Testi1, Ariel Vulcano1, Pierina Sansinanea1, Martin Mamberti4, Maria Elena Bruzzone4, Carolina Barabani4 and Jimena Salomone4, 1Rheumatology, HIGA General San Martin La Plata, la plata, Argentina, 2Rheumatology, HIGA General San Martin La Plata, La Plata, Argentina, 3HIGA General San Martin La Plata, la plata, Argentina, 4Nephrology, HIGA General San Martin La Plata, la plata, Argentina

    Background/Purpose: The pauci-immune nature of typical lesions in ANCA associated vasculitis (AAV) has led to the belief that complement does not play a role in…
  • Abstract Number: 2813 • ACR/ARHP Annual Meeting 2016

    Risk of Renal Failure within 10 or 20 Years of SLE Diagnosis, By Patient Characteristics

    Laurence S Magder1, Erik Barr2 and Michelle Petri3, 1Epidemiology and Public Health, Division of Rheumatology, School of Medicine, Johns Hopkins University, Baltimore, MD, 2Epidemiology, University of Maryland, Baltimore, MD, 3Rheumatology Division, Johns Hopkins University School of Medicine, Baltimore, MD

    Background/Purpose:   Patients with systemic lupus erythematosus (SLE) are at elevated risk for lupus nephritis and ultimately renal failure.  While some risk factors for renal…
  • Abstract Number: 3087 • ACR/ARHP Annual Meeting 2015

    Cell Bound Complement Activation Products in Multianalyte Assay with Algorithm Have Utility in Distinguishing Primary Fibromyalgia from Systemic Lupus Erythematosus

    Daniel Wallace1, Stuart L. Silverman2, Derren Barken3, John Conklin4 and Thierry Dervieux5, 1Cedars-Sinai/UCLA, Los Angeles, CA, 2OMC Clinical Research Center, Beverly Hills, CA, 3Exagen Diagnostics, Vista, CA, 41261 Liberty Way Suite C, Exagen Diagnostics, Vista, CA, 5Research and Development, Exagen Diagnostics, Vista, CA

    Background/Purpose : Our objective was to prospectively establish the performance characteristics of a cell bound complement activation products (CB-CAPS) in a multi-analyte assay with algorithm…

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology